AIMS: Early detection of cardiovascular diseases and knowledge of underlying mechanisms is essential. Tissue secretome studies resemble more closely to the in vivo situation, showing a much narrower protein concentrations dynamic range than plasma. This study was aimed to the analysis of human arterial tissue secretome and to the quantitative comparison of healthy and atherosclerotic secretome to discover proteins with key roles in atherosclerosis development. METHODS AND RESULTS: Secretomes from three biological replicates of human atherosclerotic coronary arteries (APC), preatherosclerotic coronaries (PC) and mammaries (M) were analyzed by LC-MS/MS. The identified proteins were submitted to Ingenuity Pathway Analysis (IPA) tool. Label-free MS/MS based quantification was performed and validated by immunohistochemistry. 64 proteins were identified in the 3 replicates of at least one of the 3 groups and 15 secreted proteins have not been previously reported in plasma. Four proteins were significantly released in higher amounts by mammary tissue: gelsolin, vinculin, lamin A/C and phosphoglucomutase 5. CONCLUSION: The study of tissue secretome reveals key proteins involved in atherosclerosis which have not been previously reported in plasma. Novel proteins are here highlighted which could be potential therapeutic targets in clinical practice. This article is part of a Special Issue entitled: Proteomics: The clinical link.
AIMS: Early detection of cardiovascular diseases and knowledge of underlying mechanisms is essential. Tissue secretome studies resemble more closely to the in vivo situation, showing a much narrower protein concentrations dynamic range than plasma. This study was aimed to the analysis of human arterial tissue secretome and to the quantitative comparison of healthy and atherosclerotic secretome to discover proteins with key roles in atherosclerosis development. METHODS AND RESULTS: Secretomes from three biological replicates of humanatherosclerotic coronary arteries (APC), preatherosclerotic coronaries (PC) and mammaries (M) were analyzed by LC-MS/MS. The identified proteins were submitted to Ingenuity Pathway Analysis (IPA) tool. Label-free MS/MS based quantification was performed and validated by immunohistochemistry. 64 proteins were identified in the 3 replicates of at least one of the 3 groups and 15 secreted proteins have not been previously reported in plasma. Four proteins were significantly released in higher amounts by mammary tissue: gelsolin, vinculin, lamin A/C and phosphoglucomutase 5. CONCLUSION: The study of tissue secretome reveals key proteins involved in atherosclerosis which have not been previously reported in plasma. Novel proteins are here highlighted which could be potential therapeutic targets in clinical practice. This article is part of a Special Issue entitled: Proteomics: The clinical link.
Authors: Gloria Alvarez-Llamas; Tatiana Martín-Rojas; Fernando de la Cuesta; Enrique Calvo; Felix Gil-Dones; Veronica M Dardé; Luis F Lopez-Almodovar; Luis R Padial; Juan-Antonio Lopez; Fernando Vivanco; Maria G Barderas Journal: Mol Cell Proteomics Date: 2013-05-23 Impact factor: 5.911
Authors: Sara Zanivan; Federica Maione; Marco Y Hein; Juan Ramon Hernández-Fernaud; Pawel Ostasiewicz; Enrico Giraudo; Matthias Mann Journal: Mol Cell Proteomics Date: 2013-08-26 Impact factor: 5.911
Authors: Carlos M Laborde; Sergio Alonso-Orgaz; Laura Mourino-Alvarez; José Moreu; Fernando Vivanco; Luis R Padial; María G Barderas Journal: Proteome Sci Date: 2014-10-10 Impact factor: 2.480
Authors: Alberto Benito-Martin; Alvaro Conrado Ucero; Irene Zubiri; Maria Posada-Ayala; Beatriz Fernandez-Fernandez; Pablo Cannata-Ortiz; Maria Dolores Sanchez-Nino; Marta Ruiz-Ortega; Jesus Egido; Gloria Alvarez-Llamas; Alberto Ortiz Journal: PLoS One Date: 2013-08-23 Impact factor: 3.240
Authors: Marta Martin-Lorenzo; Irene Zubiri; Aroa S Maroto; Laura Gonzalez-Calero; Maria Posada-Ayala; Fernando de la Cuesta; Laura Mourino-Alvarez; Luis F Lopez-Almodovar; Eva Calvo-Bonacho; Luis M Ruilope; Luis R Padial; Maria G Barderas; Fernando Vivanco; Gloria Alvarez-Llamas Journal: Metabolomics Date: 2014-12-14 Impact factor: 4.290